XML 41 R32.htm IDEA: XBRL DOCUMENT v3.24.3
Share Capital (Tables)
9 Months Ended
Sep. 30, 2024
Disclosure of Share Capital [Line Items]  
Schedule of Common Stock Outstanding Roll Forward

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:

 

 

 

Issued and Outstanding

 

 

Subordinate
Voting
Shares

 

Multiple
Voting
Shares

 

Super
Voting
Shares

As at January 1, 2024

 

209,871,792

 

38,531

 

216,690

Distribution of contingent consideration

 

1,250,000

 

 

Issuance of shares upon exercise of options

 

1,331,937

 

 

Issuances of shares upon vesting of RSUs

 

905,176

 

 

Repurchase of Subordinate Voting Shares

 

(2,725,000)

 

 

Exchange of shares

 

1,084,800

 

(848)

 

(10,000)

As at September 30, 2024

 

211,718,705

 

37,683

 

206,690

Share-based Payment Arrangement, Option, Activity

Stock option activity is summarized as follows:

 

Number of Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life

Balance as of December 31, 2023

10,071,467

$11.75

4.31

Granted

797,289

14.96

 

Exercised

(1,331,937)

8.66

 

Forfeited

(1,044,836)

14.06

 

Balance as of September 30, 2024

8,491,983

$12.65

4.44

Exercisable as of September 30, 2024

3,400,436

$7.66

3.87

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the nine months ended September 30, 2024 and the year ended December 31, 2023, using the following ranges of assumptions:

 

September 30,

December 31,

 

2024

2023

Risk-free interest rate

3.02% - 3.92%

3.06% - 4.32%

Expected dividend yield

0%

0%

Expected volatility

62% - 64%

64%

Expected option life

4.46 - 4.5 years

3.5 – 4.5 years

Schedule of Stock-Based Compensation Expense

The stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 was as follows:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2024

 

2023

 

2024

 

2023

 

 

(in thousands)

 

(in thousands)

Stock options expense

$

2,387

$

4,009

$

8,081

$

12,795

Restricted Stock Units

 

5,962

 

3,206

 

15,624

 

8,040

Total Stock Based Compensation Expense

$

8,349

$

7,215

$

23,705

$

20,835

Restricted Stock Units  
Disclosure of Share Capital [Line Items]  
Non-vested Restricted Stock Shares Activity

The following table summarizes the number of unvested RSU awards as of September 30, 2024 and December 31, 2023 and the changes during the nine months ended September 30, 2024:

 

 

Number of Shares

 

Weighted Average Grant Date Fair Value

Unvested Shares at December 31, 2023

 

3,620,638

$

9.25

Granted

 

2,635,868

 

14.45

Forfeited

 

(789,511)

 

11.62

Vested

 

(905,176)

 

9.86

Unvested Shares at September 30, 2024

 

4,561,819

$

11.52